Screener / SEC EDGAR /CIK 0001287865 /10-K filed Feb 26, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Real estate · REIT

Medical Properties Trust Inc MPT

Compare with peers Embed
FY2025 at a glance

Sales down 2.4%

XBRL, from each 10-K
RevenueStatements
$972.0M from $995.5M in FY2024
FY2016FY2025
Net incomeStatements
-$277.0M from -$2.4B in FY2024
FY2016FY2025
EPS (diluted)Statements
$-0.46 from $-4.02 in FY2024
FY2016FY2025
Total debtStatements
$9.7B from $8.8B in FY2024
FY2016FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (29)
EPS (ttm)
-0.21
Sales (ttm)
1.0B
Net income (ttm)
-125.9M
Sales growth
-2.4%
EPS growth
-
Sales Q/Q
+12.6%
Free cash flow
-
Gross margin
90.7%
Oper. margin
-
Net margin
-12.6%
FCF margin
-
R&D / sales
-
Dividend
0.33
Debt/Eq
2.13
Curr. ratio
-
Cash
425.0M
Op. cash flow (ttm)
216.1M
Net debt
9.2B
Stock pay / sales
2.6%
Shares out.
598.1M
Shares Y/Y
+0.1%
Book / share
7.60
Cash / share
0.71
Sales / share
1.67
Asset turnover
0.07
Sales 3Y CAGR
-14.3%
Sales 5Y CAGR
-4.9%

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2016 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 972.0M +6.7% a year Net income -277.0M
FY2016 revenue 541.1M · Revenues, 0001564590-19-005843 FY2016 net income 225.0M · NetIncomeLoss, 0001564590-19-005843 541.1M FY2016 FY2017 revenue 704.7M · Revenues, 0001564590-20-006950 FY2017 net income 289.8M · NetIncomeLoss, 0001564590-20-006950 704.7M FY2017 FY2018 revenue 784.5M · Revenues, 0001564590-21-009901 FY2018 net income 1.0B · NetIncomeLoss, 0001564590-21-009901 784.5M FY2018 FY2019 revenue 854.2M · Revenues, 0001564590-22-008100 FY2019 net income 374.7M · NetIncomeLoss, 0001564590-22-008100 854.2M FY2019 FY2020 revenue 1.2B · Revenues, 0000950170-23-005575 FY2020 net income 431.4M · NetIncomeLoss, 0000950170-23-005575 1.2B FY2020 FY2021 revenue 1.5B · Revenues, 0000950170-24-023248 FY2021 net income 656.0M · NetIncomeLoss, 0000950170-24-023248 1.5B FY2021 FY2022 revenue 1.5B · Revenues, 0000950170-25-030989 FY2022 net income 902.6M · NetIncomeLoss, 0000950170-25-030989 1.5B FY2022 FY2023 revenue 871.8M · Revenues, 0001193125-26-073587 FY2023 net income -556.5M · NetIncomeLoss, 0001193125-26-073587 871.8M FY2023 FY2024 revenue 995.5M · Revenues, 0001193125-26-073587 FY2024 net income -2.4B · NetIncomeLoss, 0001193125-26-073587 995.5M FY2024 FY2025 revenue 972.0M · Revenues, 0001193125-26-073587 FY2025 net income -277.0M · NetIncomeLoss, 0001193125-26-073587 972.0M FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2016 to FY2025 (9 years).

Growth per share, FY2015 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Book value per share -2.3% a year FY2015 $9.63 to FY2025 $7.67, 10 years
Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 31, 2025 -$0.46$7.67-
Dec 31, 2024 -$4.02$8.05-
Dec 31, 2023 -$0.93$12.75-
Dec 31, 2022 $1.50$14.35-
Dec 31, 2021 $1.11$14.30-
Dec 31, 2020 $0.81$13.83-
Dec 31, 2019 $0.87$16.41-
Dec 31, 2018 $2.76$12.41-
Dec 31, 2017 $0.82$10.90-
Dec 31, 2016 $0.86$12.44-
Dec 31, 2015 $0.63$9.63-

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Tangible book value, FY2025, in dollars
  • + Shareholders' equity $4.6B
  • = Tangible book value $4.6B
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

MPT against Real estate peers

Among the 97 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+1.3%+10.4%
-2.4%77th of 89 · median +6.1%
Net margin
5.9%35.6%
-12.6%86th of 90 · median 19.9%
Return on equity
2.5%11.3%
-2.8%83rd of 93 · median 7.0%
Debt / equity (less is better)
1.340.53
2.1366th of 74 · median 0.85
MPT and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
MPT Medical Properties Trust Inc$1.0B -2.4%90.7%-12.6%-2.8%-2.13
DEI Douglas Emmett Inc$1.0B +1.8%62.6%-2.0%-1.1%-3.14
SLG SL Green Realty Corp$1.0B +13.2%--15.8%-4.5%--
MAC Macerich Co$1.0B +10.4%--9.8%-3.6%-1.62
REXR Rexford Industrial Realty, Inc.$977.8M +7.1%--47.1%-6.4%-0.39
NNN NNN Reit, Inc.$972.8M +6.6%-40.9%8.7%-0.04
All 97 companies in the group

Where each dollar goes

Revenue through the costs to the net profit, from the 10-K income statement

From $1.5B of sales to $656.0M of profit FY2021

Revenue to Gross profit: $1.4BRevenue to Cost of revenue: $101.4MGross profit to Net profit: $656.0MGross profit to Costs, tax, other: $787.2M Revenue: $1.5B REVENUE $1.5B +24% Y/Y Gross profit: $1.4B · 93% margin GROSS PROFIT $1.4B 93% margin Cost of revenue: $101.4M · 7% of revenue COST OF REVENUE $101.4M 7% of revenue Net profit: $656.0M · 42% margin NET PROFIT $656.0M 42% margin · +52% Y/Y Costs, tax, other: $787.2M · 51% of revenue COSTS, TAX, OTHER $787.2M 51% of revenue

From $1.5B of sales to $902.6M of profit FY2022

Revenue to Gross profit: $1.4BRevenue to Cost of revenue: $167.4MGross profit to Net profit: $902.6MGross profit to Costs, tax, other: $472.8M Revenue: $1.5B REVENUE $1.5B +0% Y/Y Gross profit: $1.4B · 89% margin GROSS PROFIT $1.4B 89% margin Cost of revenue: $167.4M · 11% of revenue COST OF REVENUE $167.4M 11% of revenue Net profit: $902.6M · 59% margin NET PROFIT $902.6M 59% margin · +38% Y/Y Costs, tax, other: $472.8M · 31% of revenue COSTS, TAX, OTHER $472.8M 31% of revenue

Where each $100 of sales went

FY2021
FY2022
  • Cost of revenue
  • Costs, tax, other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2020 · 10-K XBRL, year-end balances

Return on equity -6.0% FY2020: 5.9% net income ÷ equity
Net margin -28.5% FY2020: 34.5% profit per $ of sales: -277.0M ÷ 972.0M
Asset turnover 0.06× FY2020: 0.07× sales per $ of assets: 972.0M ÷ 15.0B
Leverage 3.26× FY2020: 2.29× assets per $ of equity: 15.0B ÷ 4.6B

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin below the peer median
    -12.6% vs 19.9%
  • Return on equity below 15%
    -2.8%
  • A profit in 7 of 10 years
Net margin, FY2016 to FY2025: 41.6% to -28.5%

Cash and shareholders

  • Share count up over 5 years
    +13.3%
  • Dividend per share not up over 5 years
    $1.08 → $0.33

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

$3.8B of principal due, schedule of Mar 31, 2026

Debt

Repayment schedule

From the balance sheet in the latest 10-K or 10-Q (XBRL). When each part falls due, year by year, and the debt note's own lines are on the Debt tab.

Contracted revenue and deferred revenue

Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL

Contract liabilities

Paid in advance $18.6M cash received before delivery, not yet recognized as revenue, Mar 31, 2026 · -27.1% on a year earlier

Both are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

MPT's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 10. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue972.0M
FY2016: 541.1MFY2017: 704.7MFY2018: 784.5MFY2019: 854.2MFY2020: 1.2BFY2021: 1.5BFY2022: 1.5BFY2023: 871.8MFY2024: 995.5MFY2025: 972.0M FY2017FY2019FY2021FY2023FY2025
Net income-277.0M
FY2016: 225.0MFY2017: 289.8MFY2018: 1.0BFY2019: 374.7MFY2020: 431.4MFY2021: 656.0MFY2022: 902.6MFY2023: -556.5MFY2024: -2.4BFY2025: -277.0M FY2017FY2019FY2021FY2023FY2025
EPS (diluted)-0.46
FY2016: 0.86FY2017: 0.82FY2018: 2.76FY2019: 0.87FY2020: 0.81FY2021: 1.11FY2022: 1.50FY2023: -0.93FY2024: -4.02FY2025: -0.46 FY2017FY2019FY2021FY2023FY2025
Dividend per share0.33
FY2016: 0.91FY2017: 0.96FY2018: 1.00FY2019: 1.02FY2020: 1.08FY2021: 1.12FY2022: 1.16FY2023: 0.88FY2024: 0.46FY2025: 0.33 FY2017FY2019FY2021FY2023FY2025
Diluted shares600.9M
FY2016: 261.1MFY2017: 350.4MFY2018: 366.3MFY2019: 428.3MFY2020: 530.5MFY2021: 590.1MFY2022: 598.8MFY2023: 598.5MFY2024: 600.2MFY2025: 600.9M FY2017FY2019FY2021FY2023FY2025

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue541.1M704.7M784.5M854.2M1.2B1.5B1.5B871.8M995.5M972.0M
Cost of revenue--84.2M168.2M30.1M101.4M167.4M110.1M74.2M90.3M
SG&A48.9M58.6M81.0M96.4M131.7M145.6M160.5M145.6M133.8M130.4M
Operating income341.6M485.6M--------
Interest expense159.6M177.0M223.3M237.8M328.7M367.4M359.0M411.2M417.8M510.4M
Pretax income219.1M293.9M1.0B373.8M463.3M730.9M959.7M-686.8M-2.4B-237.3M
Income tax-6.8M2.7M927K-2.6M31.1M73.9M55.9M-130.7M44.1M38.6M
Net income225.0M289.8M1.0B374.7M431.4M656.0M902.6M-556.5M-2.4B-277.0M
EPS (diluted)0.860.822.760.870.811.111.50-0.93-4.02-0.46
Diluted shares261.1M350.4M366.3M428.3M530.5M590.1M598.8M598.5M600.2M600.9M
Depreciation & amortization97.6M132.0M141.5M156.6M276.0M333.8M345.6M616.1M453.7M272.8M
EBITDA439.2M617.6M--------
Operating margin63.1%68.9%--------
Net margin41.6%41.1%129.6%43.9%34.5%42.5%58.5%-63.8%-242.1%-28.5%
Revenue growth+22.5%+30.2%+11.3%+8.9%+46.2%+23.6%-0.1%-43.5%+14.2%-2.4%
EPS growth+36.5%-4.7%+237%-68.5%-6.9%+37.0%+35.1%to a loss--

Balance sheet

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash83.2M171.5M820.9M1.5B549.9M459.2M235.7M250.0M332.3M540.9M
Total assets6.4B9.0B8.8B14.5B16.8B20.5B19.7B18.3B14.3B15.0B
Total debt2.9B4.9B4.0B7.0B8.9B11.3B10.3B10.1B8.8B9.7B
Total liabilities3.2B5.2B4.3B7.4B9.5B12.1B11.1B10.7B9.5B10.4B
Shareholders' equity3.2B3.8B4.5B7.0B7.3B8.4B8.6B7.6B4.8B4.6B
Retained earnings-434.1M-485.9M162.8M83.0M-71.4M-87.7M116.3M-971.8M-3.7B-4.1B

Cash flow

From EDGAR

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)7.9M9.9M16.5M32.2M47.2M52.1M49.4M33.2M33.0M25.7M
Stock-based pay / revenue1.5%1.4%2.1%3.8%3.8%3.4%3.2%3.8%3.3%2.6%
Operating lease cost---9.3M9.9M10.7M12.2M11.7M10.7M9.3M
Operating lease cash paid---5.9M6.1M7.2M7.2M8.2M8.4M8.0M
Finance lease principal paid---10K------
Right-of-use assets---9.9M8.2M7.5M----
Operating lease liabilities--84.0M76.4M90.0M85.2M101.6M101.8M78.6M72.0M
Finance lease liabilities---1.9M1.9M1.9M1.9M1.9M1.9M1.9M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MPT/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.